CLINICAL_TRIALS trial_result · 2026-08-13

Clinical Trial Results: A Phase 2 Clinical Trial of VLA1553 in Healthy Children Aged 1 to 11 Years [Phase 2]

Phase 2 clinical trial results of VLA1553 in healthy children aged 1 to 11 years have been completed and results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Valneva Austria GmbH | Conditions: Chikungunya Virus Infection | Phase 2 | Status: COMPLETED | Results posted: 2026-08-13